Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain?

Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain?

The existing literature offers limited experimental evidence on the role of botulinum neurotoxin type E (BoNT-E) in pain transmission. The present study investigated the antinociceptive effects of subcutaneously administered BoNT-E in chronic orofacial pain conditions. This study used orofacial form...

Full description

Saved in:
Bibliographic Details
Main Authors: Sung-Koog Jung, Yu-Mi Kim, Min-Jeong Jo, Jo-Young Son, Jin-Sook Ju, Min-Kyoung Park, Min-Kyung Lee, Jae-Young Kim, Jeong-Sun Nam, Dong-Kuk Ahn
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Toxins
Subjects:
botulinum toxin type E
antinociception
formalin
complete Freund’s adjuvant
trigeminal neuropathic pain
Online Access:https://www.mdpi.com/2072-6651/17/3/130
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items